Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marino Paroli

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Journal of Autoimmunity|February 20, 2019
Counter-regulation of regulatory T cells by autoreactive CD8<sup>+</sup> T cells in rheumatoid arthritisIlenia Cammarata, Carmela Martire, Alessandra Citro, et al.
Communications Biology|February 27, 2020
Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigensAlessio Grimaldi, Ilenia Cammarata, Carmela Martire, et al.
Journal of Clinical Medicine|February 15, 2022
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term StudySimone Parisi, Andrea Becciolini, Maria Chiara Ditto, et al.
Clinical Rheumatology|July 7, 2022
Apremilast retention rate in clinical practice: observations from an Italian multi-center studyAlarico Ariani, Simone Parisi, Patrizia Del Medico, et al.
Mediterranean Journal of Rheumatology|January 31, 2025
Baseline Ultrasound Assessment Improves the Response to Apremilast in Patients with Psoriatic Arthritis: Results from a Multicentre StudyAntonella Farina, Patrizia Del Medico, Simone Parisi, et al.
Biomedicines|February 25, 2023
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric StudyAndrea Becciolini, Simone Parisi, Patrizia Del Medico, et al.
Journal of Clinical Medicine|June 28, 2023
Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter StudyAlberto Lo Gullo, Andrea Becciolini, Simone Parisi, et al.
Current Research in Pharmacology and Drug Discovery|February 29, 2024
Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patientsSimone Parisi, Becciolini Andrea, Ditto Maria Chiara, et al.
Medicina (Kaunas, Lithuania)|August 26, 2023
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort StudyMarino Paroli, Andrea Becciolini, Elena Bravi, et al.
Medicina (Kaunas, Lithuania)|January 8, 2025
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup-A Multicenter StudyMarta Priora, Andrea Becciolini, Eleonora Celletti, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Journal of Autoimmunity|February 20, 2019
Counter-regulation of regulatory T cells by autoreactive CD8<sup>+</sup> T cells in rheumatoid arthritisIlenia Cammarata, Carmela Martire, Alessandra Citro, et al.
Communications Biology|February 27, 2020
Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigensAlessio Grimaldi, Ilenia Cammarata, Carmela Martire, et al.
Journal of Clinical Medicine|February 15, 2022
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term StudySimone Parisi, Andrea Becciolini, Maria Chiara Ditto, et al.
Clinical Rheumatology|July 7, 2022
Apremilast retention rate in clinical practice: observations from an Italian multi-center studyAlarico Ariani, Simone Parisi, Patrizia Del Medico, et al.
Mediterranean Journal of Rheumatology|January 31, 2025
Baseline Ultrasound Assessment Improves the Response to Apremilast in Patients with Psoriatic Arthritis: Results from a Multicentre StudyAntonella Farina, Patrizia Del Medico, Simone Parisi, et al.
Biomedicines|February 25, 2023
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric StudyAndrea Becciolini, Simone Parisi, Patrizia Del Medico, et al.
Journal of Clinical Medicine|June 28, 2023
Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter StudyAlberto Lo Gullo, Andrea Becciolini, Simone Parisi, et al.
Current Research in Pharmacology and Drug Discovery|February 29, 2024
Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patientsSimone Parisi, Becciolini Andrea, Ditto Maria Chiara, et al.
Medicina (Kaunas, Lithuania)|August 26, 2023
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort StudyMarino Paroli, Andrea Becciolini, Elena Bravi, et al.
Medicina (Kaunas, Lithuania)|January 8, 2025
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup-A Multicenter StudyMarta Priora, Andrea Becciolini, Eleonora Celletti, et al.
Pageof 7